Get App
The Indian pharmaceutical sector is expected to see a moderate revenue growth of 9% in fiscal year 2022, compared with a revenue growth of 12.5% in the last financial year, due to sluggishness in exports, according to Crisil Rating agency. ...
The Indian pharmaceutical sector is expected to see a moderate revenue growth of 9% in fiscal year 2022, compared with a revenue growth of 12.5% in the last financial year, due to sluggishness in exports, according to Crisil Rating agency. ...